Identifies a luminescent antibacterial compound targeting Gram-negative bacteria, suggesting a novel treatment approach for infections.
Infections caused by multidrug-resistant (MDR) Gram-negative bacteria represent a critical global health challenge, necessitating the urgent identification of new antibacterial targets to improve drug discovery and development. In this study,...
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: